These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8816125)

  • 1. Photo quiz. Pepto Bismol poisoning.
    Hearney EG; Fuhrer J; Marioz P
    Clin Infect Dis; 1996 Jul; 23(1):37,159. PubMed ID: 8816125
    [No Abstract]   [Full Text] [Related]  

  • 2. Bismuth absorption and myoclonic encephalopathy during bismuth subsalicylate therapy.
    Mendelowitz PC; Hoffman RS; Weber S
    Ann Intern Med; 1990 Jan; 112(2):140-1. PubMed ID: 2294817
    [No Abstract]   [Full Text] [Related]  

  • 3. Bismuth subsalicylate: history, chemistry, and safety.
    Bierer DW
    Rev Infect Dis; 1990; 12 Suppl 1():S3-8. PubMed ID: 2406853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal salicylate toxicity from bismuth subsalicylate.
    Sainsbury SJ
    West J Med; 1991 Dec; 155(6):637-9. PubMed ID: 1812638
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic salicylate toxicity due to consumption of over-the-counter bismuth subsalicylate.
    Vernace MA; Bellucci AG; Wilkes BM
    Am J Med; 1994 Sep; 97(3):308-9. PubMed ID: 8092182
    [No Abstract]   [Full Text] [Related]  

  • 6. The absorption of bismuth and salicylate from oral doses of Pepto-Bismol (bismuth salicylate).
    Nwokolo CU; Mistry P; Pounder RE
    Aliment Pharmacol Ther; 1990 Apr; 4(2):163-9. PubMed ID: 2104082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case 1: Mysteriously Rising Salicylate Levels in a 15-year-old Girl.
    Parker V; Goldberg D; King MA
    Pediatr Rev; 2017 Jun; 38(6):280-281. PubMed ID: 28572137
    [No Abstract]   [Full Text] [Related]  

  • 8. Aspirin and bismuth subsalicylate.
    Levy G
    Am J Dis Child; 1993 Dec; 147(12):1281. PubMed ID: 8249944
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of histamine H2-receptor blockade on bismuth absorption from three ulcer-healing compounds.
    Nwokolo CU; Prewett EJ; Sawyerr AM; Hudson M; Pounder RE
    Gastroenterology; 1991 Oct; 101(4):889-94. PubMed ID: 1889712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bismuth Subsalicylate Poisoning.
    Meaden CW; Calello DP
    N Engl J Med; 2022 Dec; 387(22):2074. PubMed ID: 36449423
    [No Abstract]   [Full Text] [Related]  

  • 11. Pepto-Bismol mimicking pancreatic calcification.
    Bernstein D; Barkin JS
    Am J Gastroenterol; 1992 Nov; 87(11):1677-9. PubMed ID: 1442703
    [No Abstract]   [Full Text] [Related]  

  • 12. Bismuth Subsalicylate Coagulopathy in a Patient with Chronic Liver Disease.
    Yu C; Eustaquio N; Calello DP; Ruck BE; Nelson LS; Santos C
    J Med Toxicol; 2019 Jul; 15(3):198-201. PubMed ID: 31062178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative absorption of bismuth in Sprague-Dawley rats following oral administration of preparations containing bismuth sucrose octasulfate, bismuth subsalicylate, and bismuth subcitrate.
    Rao N; Brown PW; Yerino P; Chang J; Hwang KK
    Biopharm Drug Dispos; 1997 Jan; 18(1):1-8. PubMed ID: 9008264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encephalopathy from abuse of bismuth subsalicylate (Pepto-Bismol).
    Jungreis AC; Schaumburg HH
    Neurology; 1993 Jun; 43(6):1265. PubMed ID: 8192812
    [No Abstract]   [Full Text] [Related]  

  • 15. Absorption of salicylate and bismuth from a bismuth subsalicylate--containing compound (Pepto-Bismol).
    Pickering LK; Feldman S; Ericsson CD; Cleary TG
    J Pediatr; 1981 Oct; 99(4):654-6. PubMed ID: 7277115
    [No Abstract]   [Full Text] [Related]  

  • 16. Salicylate in Pepto-Bismol.
    Med Lett Drugs Ther; 1980 Jul; 22(15):63. PubMed ID: 7393125
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral absorption and drug interaction kinetics of moxifloxacin in an animal model of weightlessness.
    Liang D; Ma J; Wei B
    Sci Rep; 2021 Jan; 11(1):2605. PubMed ID: 33510326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pepto-bismol and salicylate levels.
    Shanbrom E
    Mayo Clin Proc; 1989 Jan; 64(1):129. PubMed ID: 2911212
    [No Abstract]   [Full Text] [Related]  

  • 19. [In vitro effect of 2 pharmaceutical preparations containing bismuth on the fermentative capacity of intestinal bacteria].
    León-Barúa R; Tello-Casanova R
    Acta Gastroenterol Latinoam; 1985; 15(3):157-64. PubMed ID: 3836544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of gastrointestinal blood loss in the feces of rats following Pepto-Bismol liquid and aspirin administration.
    Goldenberg MM; Brooks RR; Boise KL
    Life Sci; 1980 Apr; 26(16):1335-42. PubMed ID: 6966730
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.